 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Foundations of Longitudinal Optical Imaging and Preclinical Models

The Translational Purpose of Longitudinal Optical Imaging

Neurodegenerative Models and Their Translational Scope

Methodology, Two-Photon Microscopy, and Artefact Management

Imaging Proteinopathies in Preclinical Models

Optical Imaging of Amyloid and Tau Pathology

Alpha-Synuclein and Emerging Proteinopathies

Cellular, Network, and Glial Dysfunction

Synapses, Neurites, and Calcium Network Imaging

Microglia, Astrocytes, and the Neuroinflammatory Response

Vascular, Retinal, and Whole-Brain Imaging Approaches

Vascular, Oxygenation, and Hemodynamic Change

Retinal Optical Biomarkers

Whole-Brain Clearing and Multiscale Imaging

Treatment Response, Translation, and Evidence Evaluation

Assessing Treatment Response and Target Engagement

The Evidence Ladder and Progression Measurement

Navigating Translation Barriers and Stakeholder Alignment

Knowledge Assessments

Quiz: Foundations of Longitudinal Imaging

Quiz: Model Selection and Variables

Quiz: Two-Photon Microscopy and Artefact Management

Quiz: Proteinopathy Probes and FLIM

Quiz: Network Dysfunction and Calcium Imaging

Quiz: Glial Responses and Neuroinflammation

Quiz: Neurovascular and Retinal Imaging

Quiz: Whole-Brain Clearing and Multimodality

Quiz: Target Engagement and Treatment Response

Quiz: The Evidence Ladder and Translational Barriers

Course Surveys and Feedback

Survey: Course Relevance and Foundation Assessment

Survey: Disease Model Applicability

Survey: Imaging Modalities and Technical Focus

Survey: Biomarker Translation Feasibility

Survey: Quality of Illustrative Case Scenarios

Survey: Application of the Evidence Ladder

Survey: Navigating Translation Barriers

Survey: Stakeholder Alignment Evaluation

Survey: Professional Impact and Next Steps

Survey: Final Course Evaluation

Welcome to "Optical Imaging of Neurodegenerative Disease Progression in Models," a comprehensive and advanced course designed for researchers, imaging scientists, and translational biologists. Neurodegenerative diseases, such as Alzheimer's and Parkinson's, present complex pathological cascades that require precise, longitudinal tracking to fully understand and treat.

Welcome to "Optical Imaging of Neurodegenerative Disease Progression in Models," a comprehensive and advanced course designed for researchers, imaging scientists, and translational biologists. Neurodegenerative diseases, such as Alzheimer's and Parkinson's, present complex pathological cascades that require precise, longitudinal tracking to fully understand and treat. Traditional cross-sectional histology often falls short in capturing the dynamic progression of these diseases. This course bridges that gap by providing an in-depth exploration of cutting-edge optical imaging techniques used in preclinical models. 

Throughout this program, you will dive into the foundations of longitudinal optical imaging, mastering the use of two-photon microscopy to track pathology in living animal models. We will explore how to effectively image proteinopathies, including amyloid, tau, and alpha-synuclein, utilizing advanced methods like Fluorescence Lifetime Imaging (FLIM). Beyond protein aggregates, you will learn to assess cellular and network dysfunction, monitoring synapses, calcium networks, and the neuroinflammatory responses of microglia and astrocytes. 

The curriculum also covers multiscale approaches, from vascular and retinal optical biomarkers (like OCT) to whole-brain clearing techniques. Crucially, this course emphasizes the translational purpose of these imaging modalities. You will learn how to evaluate treatment responses, apply a rigorous "Evidence Ladder" to validate progression biomarkers, and navigate the complex barriers of clinical translation. By the end of this course, you will be equipped with the methodological expertise and critical evaluation skills necessary to design robust preclinical imaging studies that drive meaningful advancements in neurodegenerative disease research.

76. Optical Imaging of Neurodegenerative Disease Progression in Models

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>Neurodegenerative diseases present complex, dynamic pathologies that evolve over extended periods, making the accurate measurement of their progression a formidable challenge in preclinical research. Traditional cross-sectional histology, while foundational, inherently lacks the capacity to capture the precise temporal sequence of pathological events within a single subject. To bridge this critical gap, longitudinal optical imaging has emerged as an indispensable methodology. This course provides a comprehensive examination of how advanced optical imaging techniques—such as two-photon microscopy, fluorescence lifetime imaging (FLIM), and retinal optical coherence tomography (OCT)—are deployed to track disease progression in living animal models. By focusing on the continuous, in vivo monitoring of pathological hallmarks, researchers can establish highly reliable timelines of neurodegenerative events, thereby differentiating between mere pathological presence and true clinical disease progression.</p>

<p>Throughout this curriculum, participants will systematically explore the intersection of neurodegenerative models and cutting-edge imaging modalities. The modules are meticulously structured to guide learners from the foundational principles of model selection and artefact management to the nuanced imaging of specific proteinopathies, including amyloid, tau, and alpha-synuclein aggregates. Beyond isolated protein accumulation, the course investigates broader systemic changes, detailing methodologies to quantify synaptic degradation, calcium network hyperactivity, glial-mediated neuroinflammation, and neurovascular dysfunction. Crucially, the program culminates in a rigorous evaluation of translational barriers. By applying a structured "evidence ladder," neuroscientists, pharmacologists, and imaging specialists will learn to critically assess preclinical optical biomarkers for target engagement and treatment response, ensuring that fundamental research aligns with the stringent demands of clinical translation and therapeutic development.</p>
        </div>
    </div>
</div>
